UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040200
Receipt number R000045335
Scientific Title Clinical utility of preprocedural cardiovascular magnetic resonance imaging in patients undergoing percutaneous left atrial appendage closure
Date of disclosure of the study information 2020/04/20
Last modified on 2025/04/23 18:57:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical utility of preprocedural cardiovascular magnetic resonance imaging in patients undergoing percutaneous left atrial appendage closure

Acronym

LAAC-MRI study

Scientific Title

Clinical utility of preprocedural cardiovascular magnetic resonance imaging in patients undergoing percutaneous left atrial appendage closure

Scientific Title:Acronym

LAAC-MRI study

Region

Japan


Condition

Condition

non-valvular atrial fibrillation

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The perpose of this study is to compare measurements of left atrial appendage using caldiovascular magnetic resonance imaging and those using transesophageal echocardiography in patients undergoing percutaneous atrial appendage closure.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Correlation between TEE and MRI for measurements of LAA in patients undergoing LAAC.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients with atrial fibrillation who indicated for treatment of LAAC

Key exclusion criteria

The patients who are under the 20 years old or who are found unfit to be respondent to a survey by physician-in-charge

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Masahiko
Middle name
Last name Asami

Organization

Mitsui Memorial Hospital

Division name

Division of Cardiology

Zip code

101-8643

Address

1 KandaIzumi-cyo, Chiyoda-ku, Tokyo

TEL

+81338629111

Email

asami560725@yahoo.co.jp


Public contact

Name of contact person

1st name Kai
Middle name
Last name Ninomiya

Organization

Mitsui Memorial Hospital

Division name

Division of Cardiology

Zip code

101-8643

Address

1 KandaIzumi-cyo, Chiyoda-ku, Tokyo

TEL

+81338629111

Homepage URL


Email

k-ninomiya@mitsuihosp.or.jp


Sponsor or person

Institute

Mitsui Memorial Hospital

Institute

Department

Personal name



Funding Source

Organization

Self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee in Mitsui Memorial Hospital

Address

1 KandaIzumi-cyo, Chiyoda-ku, Tokyo

Tel

+81338629236

Email

c-uno@mitsuihosp.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 04 Month 20 Day


Related information

URL releasing protocol

Manuscript under submission

Publication of results

Unpublished


Result

URL related to results and publications

Manuscript under submission

Number of participants that the trial has enrolled

108

Results

Manuscript under submission

Results date posted

2025 Year 04 Month 23 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Manuscript under submission

Participant flow

Manuscript under submission

Adverse events

Manuscript under submission

Outcome measures

Manuscript under submission

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 10 Month 30 Day

Date of IRB

2020 Year 01 Month 10 Day

Anticipated trial start date

2020 Year 04 Month 24 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2020 Year 04 Month 19 Day

Last modified on

2025 Year 04 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045335